REGADENOSON - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2025-03-17
- Label type
- Indexing - Product Concept
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-05 00:25:32
Label at a glance#
ProductREGADENOSON
Active ingredientREGADENOSON
Products#
Every source-derived product name is available through these pages.
- REGADENOSON
- REGADENOSON ANHYDROUS
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| REGADENOSON | 2XLN4Y044H | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Regadenoson | REGADENOSON | Indies Pharma Jamaica Limited | 5095ab40-8503-46db-9b08-6a36f05fb5d9 | 2025-12-26 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| Regadenoson | REGADENOSON | Hospira, Inc. | 0e3f080d-b1fb-47ed-8cd3-90a4206fa704 | 2025-12-08 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| Regadenoson | REGADENOSON | Kanchan Healthcare Inc | b183399d-b8dc-4924-90cd-a1c2247742f3 | 2025-08-15 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| Regadenoson | REGADENOSON | Marlex Pharmaceuticals, Inc. | 843bfba9-47de-4d76-843a-997bb4564f6e | 2025-02-02 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| regadenoson | REGADENOSON | Baxter Healthcare Corporation | a81d66a7-b714-439e-ad7b-c7caf9d6f3b8 | 2024-09-25 | Warnings, Adverse reactions | regadenoson REGADENOSON |
| Regadenoson | REGADENOSON | Hikma Pharmaceuticals USA Inc. | 9e48b407-1ce3-461d-b48e-de183802de25 | 2024-04-10 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| regadenoson | REGADENOSON | Eugia US LLC | b553eb2d-0c3f-444e-ad4c-282328683110 | 2023-12-18 | Warnings, Adverse reactions | regadenoson REGADENOSON |
| Regadenoson | REGADENOSON | International Medication Systems, Limited | 288c76cc-ff3e-47ea-ae02-be566bd3e093 | 2023-04-20 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| Regadenoson | REGADENOSON | Dr. Reddy's Laboratories Inc. | 03ef6420-8190-a404-f7f6-def1864a77de | 2022-11-01 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| Regadenoson | REGADENOSON | Gland Pharma Limited | 5e4109f0-4875-4f8e-b70d-4055b3a785a3 | 2022-07-15 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| Regadenoson | REGADENOSON | Meitheal Pharmaceuticals Inc. | a550b451-fb30-4c1c-a60e-6e40fba20c88 | 2022-04-15 | Warnings, Adverse reactions | Regadenoson REGADENOSON |
| LEXISCAN | REGADENOSON | Astellas Pharma US, Inc. | 057289f4-2e18-4c1e-bed4-6c1858e2ef16 | 2018-12-21 | Warnings, Adverse reactions | REGADENOSON |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.